Cargando…

Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics

PURPOSE: Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare primary liver malignancy often diagnosed at advanced stages. While there are limited data on the efficacy of specific agents, we aim to report outcomes of patients treated with systemic therapies and explore prognostic factors. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da Fonseca, Leonardo G, Yamamoto, Victor Junji, Trinconi Cunha, Mateus, Torre, Giovanna Sawaya, Araujo, Raphael L C, Fonseca, Gilton Marques, Chen, Andre Tsin Chih, Chagas, Aline Lopes, Herman, Paulo, Alves, Venancio Avancini Ferreira, Carrilho, Flair Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625783/ https://www.ncbi.nlm.nih.gov/pubmed/37933267 http://dx.doi.org/10.2147/JHC.S428741

Ejemplares similares

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
por: Chagas, Aline Lopes, et al.
Publicado: (2015)

Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment
por: Da Fonseca, Leonardo G., et al.
Publicado: (2023)

Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series
por: Alencar, Regiane Saraiva de Souza Melo, et al.
Publicado: (2022)

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2018)

Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
por: Gummadi, Jyotsna, et al.
Publicado: (2023)

Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review
por: Toda, Karla Sawada, et al.
Publicado: (2015)

Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases
por: Herman, Paulo, et al.
Publicado: (2022)

Current status and future perspectives of radiomics in hepatocellular carcinoma
por: Miranda, Joao, et al.
Publicado: (2023)

Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
por: Da Fonseca, Leonardo G., et al.
Publicado: (2022)

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma
por: Graham, Rondell P, et al.
Publicado: (2018)

Brazilian Landscape of Hepatocellular Carcinoma
por: Fonseca, Leonardo G., et al.
Publicado: (2023)

Fibrolamellar Carcinoma: 2012 Update
por: Torbenson, Michael
Publicado: (2012)

Mixed fibrolamellar hepatocellular carcinoma
por: Limaiem, Faten, et al.
Publicado: (2021)

Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
por: Cunha, Mateus Trinconi, et al.
Publicado: (2021)

Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection
por: Mafeld, Sebastian, et al.
Publicado: (2018)

Fibrolamellar Carcinomas are Positive for CD68
por: Ross, Hillary M, et al.
Publicado: (2010)

Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma
por: G. Peacock, Justin, et al.
Publicado: (2013)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
por: Villa, Nicolas A., et al.
Publicado: (2015)

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
por: Kikuchi, Luciana, et al.
Publicado: (2017)

HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2018)

Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab
por: Berger, Raanan, et al.
Publicado: (2022)

Infrequent chromosome allele loss in fibrolamellar carcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Mitochondrial Mutations in Hepatocellular Carcinomas and Fibrolamellar Carcinomas
por: Vivekanandan, Perumal, et al.
Publicado: (2010)

Surgical Resection of Ruptured Fibrolamellar Hepatocellular Carcinoma
por: Minutolo, Vincenzo, et al.
Publicado: (2013)

Synchronous Fibrolamellar Hepatocellular Carcinoma and Auricular Myxoma
por: González-Cantú, Yessica M., et al.
Publicado: (2015)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015)

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
por: Suarez, Oscar, et al.
Publicado: (2018)

Spontaneous Rupture of Fibrolamellar Variant Hepatocellular Carcinoma
por: Polavarapu, Abhishek D., et al.
Publicado: (2019)

Immunohistochemical detection of procalcitonin in fibrolamellar hepatocellular carcinoma
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022)

Duodenal Recurrence of Fibrolamellar Carcinoma 12 Years After Partial Hepatectomy and Adjuvant Chemotherapy
por: Díaz Hernández, Héctor Adrián, et al.
Publicado: (2016)

Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma
por: Moreno-Luna, Laura E, et al.
Publicado: (2005)

Accuracy of transient elastography-FibroScan(®), acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
por: Ragazzo, Taisa Grotta, et al.
Publicado: (2017)

Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments
por: Kassahun, Woubet Tefera
Publicado: (2016)

Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis
por: Glavas, Dajana, et al.
Publicado: (2023)

Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma
por: Alsina, Angel E., et al.
Publicado: (2016)

Non coding RNA analysis in fibrolamellar hepatocellular carcinoma
por: Farber, Benjamin A., et al.
Publicado: (2017)

Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
por: Thakral, Nimish, et al.
Publicado: (2020)

Fibrolamellar Variant of Hepatocellular Carcinoma in a Young Female
por: Walsh, Kevin, et al.
Publicado: (2021)

Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event
por: Abdelhamed, Walaa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gel5pppt6643pq08b1ehk5jvnr